Categories: BioTechDevelopmentHumanMedtech
Biopharmaceutical company developing human enzyme therapeutics for rare genetic diseases
Location: United States, Texas, Austin
Investors 3
Funding Rounds 2
| Date | Series | Amount | Investors |
| 08.04.2016 | - | $50M | - |
| 23.03.2015 | Series B | $44M | - |
Mentions in press and media 11
| Date | Title | Description | Source |
| 05.08.2021 | Aeglea BioTherapeutics Reports Second Quarter 2021 Financial... | | prnewswire... |
| 06.05.2021 | Aeglea BioTherapeutics Launches THINK ARGININE™, a Disease E... | | prnewswire... |
| 01.12.2020 | Aeglea BioTherapeutics Receives FDA Rare Pediatric Disease D... | | prnewswire... |
| 24.11.2020 | Aeglea BioTherapeutics Announces New Presentation Time at Up... | | prnewswire... |
| 06.02.2019 | Aeglea BioTherapeutics Announces Pricing of $60.0 Million Pu... | - | orbimed.co... |
| 29.06.2016 | The biotech IPO feast flags as investors lose their appeti... | There was a time after the 2008 crash that biotech IPOs were about as popular as snow in March. B... | endpts.com... |
| 08.04.2016 | Austin-based Aeglea BioTherapeutics Goes Public and Raises $... | Aeglea BioTherapeutics went public on the NASDAQ Stock Market Thursday at $10 a share with an Initia... | siliconhil... |
| 05.08.2015 | Ten Life Sciences Companies to Watch in Central Texas | | siliconhil... |
| 27.03.2015 | Funding roundup - week ending 3/27/15 | Accel Partners, Falcon Social, Augmented Pixels, Socratic, iAngels, Realm, Hedvig, ZipMatch, Skycure... | vator.tv/n... |
| 23.03.2015 | Aeglea Biotherapeutics Raises $44M in Series B Funding | Aeglea Biotherapeutics , an Austin, Texas-based biopharmaceutical company focused on treating tumor ... | finsmes.co... |
| 24.03.2014 | Aeglea BioTherapeutics Raises $12M; Joins Austin Technology ... | Aeglea BioTherapeutics, an Austin, Texas-based early-stage drug development company working on novel... | finsmes.co... |
Show more
Reviews 0